Literature DB >> 1520317

Expression of two types of neurofibromatosis type 1 gene transcripts in gastric cancers and comparison of GAP activities.

T Uchida1, T Matozaki, T Suzuki, K Matsuda, K Wada, O Nakano, Y Konda, H Nishisaki, M Nagao, C Sakamoto.   

Abstract

To understand the molecular mechanism of gastric tumorigenesis, the status of neurofibromatosis type 1 (NF1) gene was analyzed in human gastric cancer cell lines. Although the sequencing of the GTPase activating protein (GAP)-related region of NF1 (NF1-GRD) revealed no apparent mutation, the NF1-GRD transcript (type I) and that containing an additional 63 bp insert in the center of NF1-GRD (type II) were equally expressed in most gastric cancer cells. By contrast, type II was predominantly expressed in normal stomach mucosa. When these two types of NF1-GRD were bacterially expressed and their GAP activities were tested, both types of NF1-GRD similarly stimulated ras GTPase activity. However, arachidonic acid inhibited GAP activities of two types of NF1-GRD to different extents. These results suggest that the increased expression of type I NF1 protein may modulate ras-related signal transduction and it may be related to the control of the gastric cellular proliferation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1520317     DOI: 10.1016/s0006-291x(05)81497-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  A potential role for NF1 mRNA editing in the pathogenesis of NF1 tumors.

Authors:  A J Cappione; B L French; G R Skuse
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

Review 2.  Alternative splicing of the neurofibromatosis type I pre-mRNA.

Authors:  Victoria A Barron; Hua Lou
Journal:  Biosci Rep       Date:  2012-04-01       Impact factor: 3.840

3.  NF1 gene loss of heterozygosity and expression analysis in sporadic colon cancer.

Authors:  T Cacev; S Radosević; R Spaventi; K Pavelić; S Kapitanović
Journal:  Gut       Date:  2005-04-19       Impact factor: 23.059

4.  Up-regulation of specific NF 1 gene transcripts in sporadic pilocytic astrocytomas.

Authors:  M Platten; M J Giordano; C M Dirven; D H Gutmann; D N Louis
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

5.  Immortalization of human normal and NF1 neurofibroma Schwann cells.

Authors:  Hua Li; Lung-Ji Chang; Debbie R Neubauer; David F Muir; Margaret R Wallace
Journal:  Lab Invest       Date:  2016-09-12       Impact factor: 5.662

Review 6.  The NF1 gene revisited - from bench to bedside.

Authors:  Yoon-Sim Yap; John R McPherson; Choon-Kiat Ong; Steven G Rozen; Bin-Tean Teh; Ann S G Lee; David F Callen
Journal:  Oncotarget       Date:  2014-08-15

7.  Neurofibromin level directs RAS pathway signaling and mediates sensitivity to targeted agents in malignant peripheral nerve sheath tumors.

Authors:  Elliot John Kahen; Andrew Brohl; Diana Yu; Darcy Welch; Christopher L Cubitt; Jae K Lee; Yunyun Chen; Sean J Yoder; Jamie K Teer; Yonghong O Zhang; Margaret R Wallace; Damon R Reed
Journal:  Oncotarget       Date:  2018-04-27

8.  Isoform-specific NF1 mRNA levels correlate with disease severity in Neurofibromatosis type 1.

Authors:  Antonia Assunto; Ursula Ferrara; Alessandro De Luca; Claudia Pivonello; Lisa Lombardo; Annapina Piscitelli; Cristina Tortora; Valentina Pinna; Paola Daniele; Rosario Pivonello; Maria Giovanna Russo; Giuseppe Limongelli; Annamaria Colao; Marco Tartaglia; Pietro Strisciuglio; Daniela Melis
Journal:  Orphanet J Rare Dis       Date:  2019-11-15       Impact factor: 4.123

9.  Using antisense oligonucleotides for the physiological modulation of the alternative splicing of NF1 exon 23a during PC12 neuronal differentiation.

Authors:  Josep Biayna; Helena Mazuelas; Bernat Gel; Ernest Terribas; Gabrijela Dumbovic; Inma Rosas; Juana Fernández-Rodriguez; Ignacio Blanco; Elisabeth Castellanos; Meritxell Carrió; Conxi Lazaro; Eduard Serra
Journal:  Sci Rep       Date:  2021-02-11       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.